Akero Therapeutics Inc (AKRO)

Jul 26, 2025

Jennison Associates LLC Invests $533,000 in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 26, 2025

Jul 26, 2025

Readystate Asset Management LP Acquires Shares of 100,500 Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 26, 2025

Jul 26, 2025

Teachers Retirement System of The State of Kentucky Sells 9,256 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 26, 2025

Jul 26, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Stock Holdings Lowered by Kennondale Capital Management LLC - MarketBeat

Jul 26, 2025

Jul 25, 2025

What analysts say about Akero Therapeutics Inc. stockTremendous growth potential - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

Is Akero Therapeutics Inc. a good long term investmentFast-track wealth growth - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

AstraZeneca’s Anselamimab Misses Primary Endpoint in Amyloidosis Trials, Shows Promise in Subgroup - Insider Monkey

Jul 25, 2025

Jul 24, 2025

Is Akero Therapeutics Inc. stock a growth or value playFree Trend-Following Techniques - jammulinksnews.com

Jul 24, 2025

Jul 24, 2025

How to Take Advantage of moves in (AKRO) - news.stocktradersdaily.com

Jul 24, 2025

Jul 24, 2025

Edgestream Partners L.P. Acquires Shares of 6,947 Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 24, 2025

Jul 23, 2025

What drives Akero Therapeutics Inc. stock pricePhenomenal wealth increase - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Akero Therapeutics Inc. Stock Analysis and ForecastFastest-growing stock picks - Autocar Professional

Jul 23, 2025

Jul 23, 2025

5,565 Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) Bought by Xponance Inc. - MarketBeat

Jul 23, 2025

Jul 22, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $529,500.00 in Stock - MarketBeat

Jul 22, 2025

Jul 22, 2025

Bank of New York Mellon Corp Purchases 12,235 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 22, 2025

Jul 18, 2025

257,025 Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) Purchased by Principal Financial Group Inc. - MarketBeat

Jul 18, 2025

Jul 17, 2025

Mirum Gains 35% in 3 Months: How Should You Play the Stock? - The Globe and Mail

Jul 17, 2025

Jul 17, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Receives $82.50 Average Price Target from Analysts - MarketBeat

Jul 17, 2025

Jul 16, 2025

Emerald Advisers LLC Has $11.92 Million Stock Holdings in Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 16, 2025

Jul 15, 2025

How Akero Therapeutics Inc. stock performs during market volatilityFree Stock Market Forecasting Tools - beatles.ru

Jul 15, 2025

Jul 15, 2025

Emerald Mutual Fund Advisers Trust Sells 145,145 Shares of Akero Therapeutics, Inc. (NASDAQ:AKRO) - MarketBeat

Jul 15, 2025

Jul 14, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) CEO Andrew Cheng Sells 30,000 Shares - MarketBeat

Jul 14, 2025

Jul 14, 2025

Learn to Evaluate (AKRO) using the Charts - news.stocktradersdaily.com

Jul 14, 2025

Jul 13, 2025

Akero Therapeutics, Inc. (NASDAQ:AKRO) Insider Sells $638,625.00 in Stock - MarketBeat

Jul 13, 2025